Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Baton Rouge › NPI 1942221098
Lab

Louisiana Department of Health - Office of Public Health

Louisiana Department of Health - Office of Public Health was paid $37.92M by Medicaid between Jan 2018 and Nov 2024, across 50 billing codes. Its largest line is 87591, Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe — 10.0% of everything it billed.

33Billing provider infoLOUISIANA DEPARTMENT OF HEALTH - OFFICE OF PUBLIC HEALTH
BATON ROUGE, LA 70802
33aNPI1942221098assigned 07/22/2006
28Total paid$37.92M
24GClaims2,469,943
24DCodes billed50
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Louisiana

Rank by total paid#2 of 66
Median peer was paid$253K
This provider vs. median150×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018435,820$5.56M
2019381,106$5.32M
2020390,644$6.23M
2021324,037$5.62M
2022354,564$4.86M
2023349,597$6.04M
2024incomplete234,175$4.29M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 10.0% 117,727 94,288 $3.79M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 10.0% 117,587 94,214 $3.78M
82775 9.6% 223,757 181,108 $3.66M
83789 9.1% 223,065 180,697 $3.46M
84143 9.1% 190,091 153,491 $3.44M
83021 8.5% 223,239 181,116 $3.23M
82261 8.2% 223,565 181,113 $3.12M
84443 Thyroid stimulating hormone (TSH) 7.7% 226,129 181,134 $2.92M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 6.9% 36,433 19,561 $2.60M
83516 5.3% 223,648 181,117 $2.00M
81479 Unlisted molecular pathology procedure 3.9% 164,806 133,639 $1.49M
84437 3.0% 223,667 181,129 $1.12M
38 more codes
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 1.8% 3,801 $692K
83498 1.6% 38,765 $623K
86318 1.2% 47,391 $454K
86703 1.0% 47,676 $387K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 20,366 $292K
81025 <1% 35,436 $185K
83020 <1% 13,100 $135K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 4,318 $117K
86481 <1% 1,768 $74K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,931 $69K
86780 <1% 5,356 $57K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,158 $36K
87210 <1% 10,532 $32K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,849 $31K
86803 <1% 2,284 $24K
86592 <1% 4,053 $13K
99213 Doctor's office visit, returning patient (routine) <1% 315 $12K
87116 <1% 1,410 $9K
86593 <1% 2,312 $8K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 5,233 $7K
81002 <1% 3,274 $7K
84450 <1% 2,207 $6K
85018 <1% 3,003 $6K
87206 <1% 1,390 $5K
84460 <1% 1,469 $4K
88142 <1% 4,504 $4K
82565 <1% 1,297 $4K
84550 <1% 1,454 $3K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 57 $3K
82247 <1% 1,518 $3K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 87 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 582 $2K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 4,434 $1K
82948 <1% 281 $678.13
86701 <1% 143 $477.36
36415 Collection of venous blood by venipuncture <1% 133 $170.28
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 15 $117.60
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 0% 1,327 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCROTWELL, DOROTHY (PROGRAM MANAGER)
Same official

Other billing entities under CROTWELL, DOROTHY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.